News

21Ninety on MSN1d

Serena Williams Opens Up About GLP-1 Weight Loss, Here’s What Women Should Know

Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.

Serena Williams Shows Off Her Figure in Bright Yellow Swimsuit After Announcing Weight Loss from GLP-1

Serena Williams posed in a yellow swimsuit for a series of photos shared on Instagram shortly after opening up to PEOPLE ...

Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be’

Serena Williams is opening up about her fitness journey, revealing that she uses the injectable GLP-1 weight loss drug ...

Serena Williams opens up about 31-pound weight loss using GLP-1 medication: ‘Something I suffered with’

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

GLP-1 microdosing for weight loss: Experts weigh the pros and cons

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Serena Williams Reveals the Controversial Secret Behind Her 31-Pound Weight Loss

Serena Williams has joined the growing number of people turning to GLP-1 medications as a weight-loss solution. The tennis ...

Serena Williams Gets Candid About Her GLP-1 Weight Loss: "I Feel Great"

Serena Williams is getting real about her weight-loss journey. Since April, the retired tennis legend has been on a GLP-1 ...

Serena Williams reveals GLP-1 weight loss in partnership with healthcare company Ro

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Serena Williams says she used GLP-1 for weight loss

Fox News senior medical analyst Dr. Marc Siegel joins 'Fox News Live' to discuss how tennis icon Serena Williams was able to ...

Health Rounds: GLP-1 drugs linked to lower cancer risks

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.